Antenatal Glucocorticoids Supplementation and Central Nervous System Development
Journal:
Current Drug Metabolism
Volume:
14
Page:
160-166
Author(s):
Diego Gazzolo, Laura D. Serpero, Alessandro Frigiola, Raul Abella, Alessandro Giamberti, Giovanni Li Volti and Fabrizio Michetti
Editorial (Hot Topic: Recent Advances in Neonatal Pharmacology)
Journal:
Current Drug Metabolism
Volume:
14
Page:
159-159
Author(s):
Roberto Antonucci
Synthesis and Study the Antimicrobial Activity of Novel 2-(1H-indol-3-yl)- N-(3, 4-diphenylthiazol-2(3H)-ylidene) Ethanamine Derivatives
Journal:
Medicinal Chemistry
Volume:
9
Page:
287-293
Author(s):
Ravindra M. Kumbhare, K. Vijay Kumar, Tulshiram L. Dadmal, Umesh B. Kosurkar and K. Appalanaidu
Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
Journal:
Current Drug Metabolism
Volume:
14
Page:
186-192
Author(s):
Paolo Biban and Marcella Gaffuri
Managing Comorbidity in COPD: A Difficult Task
Journal:
Current Drug Targets
Volume:
14
Page:
158-176
Author(s):
Ioanna G. Tsiligianni, Epameinondas Kosmas, Thys Van der Molen and Nikolaos Tzanakis
Antiplatelet Therapy in the Prevention of Coronary Syndromes: Mode of Action, Benefits, Drawbacks
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
11
Page:
49-57
Author(s):
Susanne M. Picker
A Surgical Opinion on Hyperalgesia/Nociception, Inflammatory/Neurogenic Pain and Anti-inflammatory Responses and Drug Interventions Revisited: Current Breakthroughs and Views
Journal:
Current Immunology Reviews (Discontinued)
Volume:
8
Page:
275-286
Author(s):
John J. Haddad
Polyglandular Autoimmune Syndromes
Journal:
Current Immunology Reviews (Discontinued)
Volume:
8
Page:
263-267
Author(s):
Khaled El Baba, Mira Zantout and Sami T. Azar
Interrelationship between Chronic Kidney Disease and Risk of Cardiovascular Diseases
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
11
Page:
38-43
Author(s):
German T. Hernandez, Michael Sippel and Debabrata Mukherjee
The Effects of Direct Renin Inhibitor, Aliskiren, on Arterial Hypertension, Chronic Kidney Disease and Cardiovascular Disease: Optimal Pharmacotherapy
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
11
Page:
77-82
Author(s):
Yoshiyuki Morishita and Eiji Kusano